Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Substance Use & Misuse|March 10, 2025
Intersecting Risk: Heat and Substance Use in Rural CommunitiesDevon Noonan, Sarah Grenon, Courtney Swinkels, et al.
Journal of Thermal Biology|June 5, 2023
Keep your cool: Overwintering physiology in response to urbanization in the acorn ant, Temnothorax curvispinosusEric G Prileson, Jordan Clark, Sarah E Diamond, et al.
Plos One|September 22, 2011
Involvement of the glycogen synthase kinase-3 signaling pathway in TBI pathology and neurocognitive outcomePramod K Dash, Daniel Johnson, Jordan Clark, et al.
Journal of Pharmaceutical Policy and Practice|July 5, 2023
Delivering the precision oncology paradigm: reduced R&D costs and greater return on investment through a companion diagnostic informed precision oncology medicines approachRaymond H Henderson, Declan French, Elaine Stewart, et al.
Journal of Virology|February 13, 2023
Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA VaccinationFatima Amanat, Jordan Clark, Juan Manuel Carreño, et al.
NPJ Vaccines|May 2, 2026
A TRAC-478-adjuvanted recombinant N1 neuraminidase influenza virus vaccine induces balanced and broadly protective immune responsesIrene Hoxie, Kirill Vasilev, Jordan Clark, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Convergent and clonotype-enriched mutations in the light chain drive affinity maturation of a public antibodyVishal Rao, Iden Sapse, Hallie Cohn, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Mpox vaccine and infection-driven human immune signaturesHallie Cohn, Nathaniel Bloom, Gianna Cai, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccinationJordan Clark, Irene Hoxie, Daniel C Adelsberg, et al.
British Journal of Haematology|October 13, 2012
Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutationsAnthony J Bench, Helen E White, Letizia Foroni, et al.
Pageof 3